BLB Solicitors
  • +01225 755656
  • enquiries@blbsolicitors.co.uk
BLB Solicitors
  • +01225 755656
  • enquiries@blbsolicitors.co.uk
  • Home
  • Services for You
    • Conveyancing Solicitors
    • Leasehold Solicitors
    • Property Dispute Solicitors
    • Divorce, Family Law and Mediation
    • Lifetime Planning and Wills
    • Probate and Estate Administration
    • Equity Release Solicitors
    • Retirement Property Conveyancing
    • Personal Injury Compensation
    • Medical Negligence Solicitors
  • Services for Business
    • Commercial Property
    • Commercial Property Disputes
    • Corporate & Commercial Legal Advice
    • Estate Management Solicitors
  • BLB Solicitors Locations
    • Almondsbury Solicitors
    • Bath Solicitors
    • Bristol Solicitors
    • Bradford on Avon Solicitors
    • Swindon Solicitors
    • Trowbridge Solicitors
  • About Us
    • Our Team
    • Working for BLB
    • BLB Solicitors – How we work
    • Making Payments to BLB Solicitors
    • Instructing BLB Solicitors
    • Terms of Business
    • Complaints Policy
    • Interest Policy
  • Blog
  • Contact Us

Home » MHRA change licence for Sodium Valproate

Medical Negligence
SSRIs
Apr 24th, 2018

At BLB Solicitors, our goal is simple – to deliver you clear, practical legal advice and cost-effective solutions. We hope you enjoy exploring our Blog. If you can’t find what you’re looking for, please do contact us.

MHRA change licence for Sodium Valproate

We have commented regularly on the Sodium Valproate birth defect scandal and, more recently, on the push for a compensation scheme. Now, amid the finding that one in five women taking the drug are still unaware of the risks during pregnancy, the Medicines and Healthcare Products Regulatory Agency (MHRA), which is an agency of the Department of Health and Social Care, has introduced a change to the drug’s licence. This change creates a requirement, among others, that the drug should not be prescribed to girls and women of childbearing age unless they provide informed written consent.

It is also recommended that those who fall into this category who are already taking the medication should contact their GP for a review.

Dr June Raine, Director of MHRA’s Vigilance and Risk Management of Medicines Division said:

“Valproate must no longer be used in any woman or girl able to have children unless she has a pregnancy prevention programme in place. This is designed to make sure patients are fully aware of the risks and the need to avoid becoming pregnant.

“These new regulatory measures also include a ban on the use of valproate for migraine or bipolar disorder during pregnancy, and a ban on the use of valproate to treat epilepsy during pregnancy unless there is no other effective treatment available.

“Patient safety is our highest priority. We are committed to making sure women and girls are aware of the very real risks of taking valproate during pregnancy. However, we also know it is important women don’t stop taking valproate without first discussing it with their doctor.”

Leading Sodium Valproate Solicitor, David Gazzard, said “I am delighted that the MHRA have stepped in to safeguard the interests of women prescribed Sodium Valproate and to ensure the safety of their unborn children. Regardless of these new measures it has always been my view that health professionals should always ensure that they have the informed consent of their patients before prescribing Sodium Valproate.”

If you have been affected by Sodium Valproate and wish to discuss matters in confidence, please feel free to call David on 01793 615011 or email him at david.gazzard@blbsolicitors.co.uk

BLB Solicitors
Request a Call Back

Recent Articles

  • Sodium valproate: the continuing scandal
  • Swindon medical negligence solicitor speaks out over report’s stark findings
  • Promising new test for sepsis wins big award
  • Sepsis compensation claim success
  • Medicines Review, to include Sodium Valproate, is underway

Newsletter Sign-up

* indicates required

Share this article

You may also like...
  • Apr 24th, 2018
    MHRA change licence for Sodium Valproate
    Read Article
  • Nov 22nd, 2018
    Sepsis compensation claim success
    Read Article
View All Related Articles
Get in-touch today
Contact Form

Left Column

Right Column

Centre

 
Sending
  • Bristol Solicitors

    0117 905 5308
  • Bath Solicitors

    01225 462871
  • Bradford on Avon Solicitors

    01225 866541
  • Swindon Solicitors

    01793 615011
  • Trowbridge Solicitors

    01225 755656
  • Almondsbury Solicitors

    0117 905 5308
Authorised & Regulated by Solicitors Regulation Authority (No. 636644)
©2025 BLB Solicitors | Terms | Privacy | Legal